According to Zhitong Finance App News, Wantai Biotech (603392.SH) disclosed its 2026 semi-annual report. During the reporting period, the company achieved operating income of 1,048 billion yuan, an increase of 24.29%; net profit loss attributable to shareholders of listed companies was 128 million yuan, a year-on-year narrowing; loss after deducting non-net profit of 169 million yuan, a year-on-year narrowing; and basic earnings per share were -0.10 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.